Effect of some peptides on dopaminergic function in man

Area of Science:

• Neuroendocrinology
• Hormone Regulation
• Dopamine Pathways

Background:

• Apomorphine HCl (Apo) is a dopamine agonist used to study pituitary hormone regulation.
• Thyrotropin-releasing hormone (TRH) and 1-desamino-8-D-arginine vasopressin (DDAVP) are key regulatory hormones.
• Dopamine (DA) plays a critical role in modulating prolactin (PRL) and growth hormone (GH) secretion.

Purpose of the Study:

• To investigate the effects of TRH and DDAVP on the growth hormone (GH) and prolactin (PRL) responses to apomorphine HCl (Apo).
• To explore the potential involvement of dopamine (DA) mechanisms in these hormonal interactions.

Main Methods:

• Administration of TRH (200 mcg IV) and DDAVP (4 mcg IV) to 10 healthy males.
• Administration of apomorphine HCl (Apo) (0.5 mg SC) to assess hormonal responses.
• Measurement of GH and PRL levels before and after drug administration.

Main Results:

• TRH and DDAVP antagonized the GH response to Apo.
• Apo did not affect basal PRL levels but antagonized the PRL response to TRH.
• DDAVP combined with Apo led to decreased PRL levels compared to placebo or DDAVP alone.

Conclusions:

• TRH may inhibit hypothalamic and pituitary lactotrophe dopamine (DA) function.
• DDAVP might facilitate lactotrophe DA function while inhibiting hypothalamic DA function.
• The precise mechanisms of these observed effects on DA pathways require further investigation.